BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3571189)

  • 1. Biochemical mechanisms of aminoglycoside cell toxicity. I. The uptake of gentamicin by cultured skin fibroblasts and the alteration of lysosomal enzyme activities.
    Oshima M; Hashiguchi M; Shindo N; Shibata S
    J Biochem; 1986 Dec; 100(6):1575-82. PubMed ID: 3571189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gentamicin-induced alterations of intralysosomal pH and lysosomal enzyme activities.
    Oshima M; Hashiguchi M; Shindo N; Shibata S
    Dev Toxicol Environ Sci; 1986; 14():91-100. PubMed ID: 3829985
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of gentamicin on the lysosomal system of cultured human proximal tubular cells. Endocytotic activity, lysosomal pH and membrane fragility.
    Regec AL; Trump BF; Trifillis AL
    Biochem Pharmacol; 1989 Aug; 38(15):2527-34. PubMed ID: 2474296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical mechanisms of aminoglycoside cell toxicity. II. Accumulation of phospholipids during myeloid body formation and histological studies on myeloid bodies using twelve aminoglycoside antibiotics.
    Oshima M; Hashiguchi M; Nakasuji M; Shindo N; Shibata S
    J Biochem; 1989 Nov; 106(5):794-7. PubMed ID: 2613686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine induces a mixed lysosomal lipidosis in cultured fibroblasts, by inactivation of acid sphingomyelinase and inhibition of phospholipase A1.
    Nassogne MC; Lizarraga C; N'Kuli F; Van Bambeke F; Van Binst R; Wallemacq P; Tulkens PM; Mingeot-Leclercq MP; Levade T; Courtoy PJ
    Toxicol Appl Pharmacol; 2004 Jan; 194(2):101-10. PubMed ID: 14736491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leupeptin and E-64, inhibitors of cysteine proteinases, prevent gentamicin-induced lysosomal phospholipidosis in cultured rat fibroblasts.
    Montenez JP; Kishore BK; Maldague P; Tulkens PM
    Toxicol Lett; 1994 Sep; 73(3):201-8. PubMed ID: 8091428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic and poly-D-glutamic acids.
    Kishore BK; Lambricht P; Laurent G; Maldague P; Wagner R; Tulkens PM
    J Pharmacol Exp Ther; 1990 Nov; 255(2):875-85. PubMed ID: 1700819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid.
    Beauchamp D; Laurent G; Maldague P; Abid S; Kishore BK; Tulkens PM
    J Pharmacol Exp Ther; 1990 Nov; 255(2):858-66. PubMed ID: 2243354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysosomal phospholipase activity is decreased in mucolipidosis II and III fibroblasts.
    Jansen SM; Groener JE; Poorthuis BJ
    Biochim Biophys Acta; 1999 Jan; 1436(3):363-9. PubMed ID: 9989267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gentamicin-induced lysosomal phospholipidosis in cultured rat fibroblasts. Quantitative ultrastructural and biochemical study.
    Aubert-Tulkens G; Van Hoof F; Tulkens P
    Lab Invest; 1979 Apr; 40(4):481-91. PubMed ID: 431047
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative toxicity of aminoglycoside antibiotics towards the lysosomes in a cell culture model.
    Tulkens P; Van Hoof F
    Toxicology; 1980; 17(2):195-9. PubMed ID: 7210003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro.
    Kishore BK; Kállay Z; Lambricht P; Laurent G; Tulkens PM
    J Pharmacol Exp Ther; 1990 Nov; 255(2):867-74. PubMed ID: 2243355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts.
    Hurwitz R; Ferlinz K; Sandhoff K
    Biol Chem Hoppe Seyler; 1994 Jul; 375(7):447-50. PubMed ID: 7945993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dimethylsulfoxide on sphingomyelinase activities in normal and Niemann-Pick type A, B and C fibroblasts.
    Sato M; Yoshida Y; Sakuragawa N; Arima M
    Biochim Biophys Acta; 1988 Sep; 962(1):59-65. PubMed ID: 2843241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on gentamicin-induced labilization of rat kidney lysosomes in vitro. Possible protection by selenium.
    Ngaha EO; Ogunleye IO
    Biochem Pharmacol; 1983 Sep; 32(18):2659-64. PubMed ID: 6626237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipramine induced lipidosis and dexamethasone effect: morphological and biochemical study in normal and chronic GM2 gangliosidosis fibroblasts.
    Palmeri S; Mangano L; Battisti C; Malandrini A; Federico A
    J Neurol Sci; 1992 Jul; 110(1-2):215-21. PubMed ID: 1506862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein C-III-1 activates lysosomal sphingomyelinase in vitro.
    Alpert AJ; Beaudet AL
    J Clin Invest; 1981 Dec; 68(6):1592-6. PubMed ID: 6274912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of weak bases in relation to intralysosomal pH in cultured human skin fibroblasts.
    Hollemans M; Elferink RO; De Groot PG; Strijland A; Tager JM
    Biochim Biophys Acta; 1981 Apr; 643(1):140-51. PubMed ID: 7236683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normalization of intracellular lysosomal hydrolases in I-cell disease fibroblasts with sucrose loading.
    Kato T; Okada S; Ohshima T; Inui K; Yutaka T; Yabuuchi H
    J Biol Chem; 1982 Jul; 257(13):7814-9. PubMed ID: 7085649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperactivity of cathepsin B and other lysosomal enzymes in fibroblasts exposed to azithromycin, a dicationic macrolide antibiotic with exceptional tissue accumulation.
    Gerbaux C; Van Bambeke F; Montenez JP; Piret J; Morlighem G; Tulkens PM
    FEBS Lett; 1996 Oct; 394(3):307-10. PubMed ID: 8830663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.